Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation

Blood

Volumn 104, Issue 6, 2004, Pages 1894-1897

  Adams, Kristina M ^a   Holmberg, Leona A ^b   Leisenring, Wendy ^b   Fefer, Alexander ^b   Guthrie, Katherine A ^b   Tylee, Tracy S ^b   McDonald, George B ^b   Bensinger, William I ^b   Nelson, J Lee ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; HLA A ANTIGEN; HLA A26 ANTIGEN; INTERLEUKIN 2; MELPHALAN; THIOTEPA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BIOPSY; CONTROLLED STUDY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HEMATOPOIETIC CELL TRANSPLANTATION; HUMAN; INCIDENCE; ISOGRAFT; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MULTIPARA; NULLIPARA; PARITY; PREGNANCY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

EID: 4444332288     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-02-0508     Document Type: Article

References (19)

1. Rappeport J, Mihm M, Reinherz E, Lopansri S, Parkman R. Acute graft-versus-host disease in recipients of bone-marrow transplants from identical twin donors. Lancet. 1979;2:717-720.
2. Hood AF, Vogelsang GB, Black LP, Farmer ER, Santos GW. Acute graft-vs-host disease: development following autologous and syngeneic bone marrow transplantation. Arch Dermatol. 1987;123:745-750.
3. Billingham R. The biology of graft-versus-host reactions. The Harvey Lecture Series, 1966-1967. Vol 62. Orlando, FL: Academic Press; 1968:21-78.
4. Hinterberger W, Rowlings PA, Hinterberger-Fischer M, et al. Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med. 1997;126:116-122.
5. Spaner D, Lowsky R, Fyles G, et al. Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient. Transplantation. 1998;66:1251-1253.
6. Einsele H, Ehninger G, Schneider EM, et al. High frequency of graft-versus-host-like syndromes following syngeneic bone marrow transplantation. Transplantation. 1988;45:579-585.
7. Glazier A, Tutschka PJ, Farmer ER, Santos GW. Graft-versus-host disease in cyclosporin Á-treated rats after syngeneic and autologous bone marrow reconstitution. J Exp Med. 1983;158:1-8.
8. Hwang WY, Goh YT, Tan CH, How GF, Tan HC. Severe acute graft-versus-host disease occurring after syngeneic BMT for AML in a patient not given prior cyclosporin a therapy. Bone Marrow Transplant. 2000;25:205-207.
9. Adams KM, Nelson JL. Microchimerism: an investigative frontier in autoimmunity and transplantation. JAMA. 2004;291:1127-1131.
10. Bryant E, Martin P. Documentation of engraftment and characterization of chimerism following hematopoietic cell transplantation. In: Thomas E, Blume K, Forman S, eds. Hematopoietic Cell Transplantation. 2nd ed, Boston, MA; Blackwell Science; 1999:197-206.
11. Kalbfleisch J, Prentice R. The Statistical Analysis of Failure Time Data. New York, NY: John Wiley and Sons; 1980:168-169.
12. Flowers ME, Pepe MS, Longton G, et al. Previous donor pregnancy as a risk factor for acute graft-versus-host disease in patients with aplastic anaemia treated by allogeneic marrow transplantation. Br J Haematol. 1990;74:492-496.
13. Kollman C, Howe CW, Anasetti C, et al. Donor characteristics as risk factors in recipients after transplantation of bone marrow from unrelated donors: the effect of donor age. Blood. 2001;98:2043-2051.
14. Verdijk RM, Kloosterman A, Pool J, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood. 2004;103:1961-1964.
15. Adams KM, Lambert NC, Heimfeld S, et al. Male DNA in female donor apheresis and CD34-enriched products. Blood. 2003;102:3845-3847.
16. Tzung SP, Hackman RC, Hockenbery DM, Bensinger W, Schiffman K, McDonald GB, Lymphocyte gastritis resembling graft-vs.-host disease following autologous hematopoietic cell transplantation. Biol Blood Marrow Transplant. 1998;4:43-48.
17. Massumoto C, Benyunes MC, Sale G, et al. Close simulation of acute graft-versus-host disease by interleukin-2 administered after autologous bone marrow transplantation for hematologic malignancy. Bone Marrow Transplant. 1996;17:351-356.
18. Holmberg L, Gooley T, Kikuchi K, et al. Gastrointestinal graft-versus-host disease after autologous stem cell transplant: incidence, outcome, and risk factors [abstract]. Biol Blood Marrow Transplant. 2004;10(supp 1):15.
19. Thein SL, Goldman JM, Galton DA. Acute "gratt-versus-host disease" after autografting for chronic granulocytic leukemia in transformation. Ann Intern Med. 1981;94:210-211.